Beximco Pharmaceuticals Limited (BXP.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In GBp
| Market Cap | 25.87B |
| Enterprise Value | 31.04B |
| P/E Ratio | 7.96 |
| PEG Ratio | 0.27 |
| Price/Sales Ratio | 1.32 |
| Price/Book Ratio | 0.61 |
| Enterprise/Revenue | 1.28 |
| Enterprise/EBITDA | 5.44 |
| Fiscal Year | June 30, 2024 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.17 |
| Operating Margin | 0.22 |
| Return On Assets | 0.06 |
| Return On Equity | 0.08 |
| Revenue | 44.39B |
| Revenue/Share | 61.41 |
| Gross Profit | 19.63B |
| EBITDA | 10.64B |
| Net Income | 5.83B |
| Diluted EPS | 13.07 |
| Total Cash | 5.15B |
| Total Cash/Share | 11.54 |
| Total Debt | 3.11B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.13 |
| Book Value Per Share | 141.39 |
| 52-Week Change | 27.27 |
| 52-Week High | 55 |
| 52-Week Low | 0.43 |
| Moving Average 50 Days | 16.86 |
| Moving Average 200 Days | 17.91 |
| Average Volume | 54,166 |
| Shares Outstanding | 446.11M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.01 |
| Last Split Factor | 11:10 |
| Last Split Date | November 23, 2020 |